Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GUTS NASDAQ:MBOT NYSE:MLSS NASDAQ:RCEL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGUTSFractyl Health$0.76-3.9%$0.80$0.38▼$2.45$125.76M2.291.23 million shs585,443 shsMBOTMicrobot Medical$1.88-0.5%$1.89$1.60▼$4.67$126.94M1.04749,947 shs417,966 shsMLSSMilestone Scientific$0.39+3.3%$0.37$0.22▼$0.68$34.89M1.051.12 million shs82,627 shsRCELAvita Medical$3.95-2.7%$4.28$3.22▼$7.12$124.95M1.86354,879 shs241,272 shsThe Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGUTSFractyl Health-3.91%-5.48%-10.39%+49.73%-49.89%MBOTMicrobot Medical-0.53%-2.59%+5.62%-22.63%-28.24%MLSSMilestone Scientific+3.30%+12.75%+12.71%+35.10%-40.80%RCELAvita Medical-2.71%-23.89%+1.02%-29.46%-30.70%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGUTSFractyl Health$0.76-3.9%$0.80$0.38▼$2.45$125.76M2.291.23 million shs585,443 shsMBOTMicrobot Medical$1.88-0.5%$1.89$1.60▼$4.67$126.94M1.04749,947 shs417,966 shsMLSSMilestone Scientific$0.39+3.3%$0.37$0.22▼$0.68$34.89M1.051.12 million shs82,627 shsRCELAvita Medical$3.95-2.7%$4.28$3.22▼$7.12$124.95M1.86354,879 shs241,272 shsThe Infrastructure's Backbone: 10 Stocks Powering the AI BuildoutThe AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGUTSFractyl Health-3.91%-5.48%-10.39%+49.73%-49.89%MBOTMicrobot Medical-0.53%-2.59%+5.62%-22.63%-28.24%MLSSMilestone Scientific+3.30%+12.75%+12.71%+35.10%-40.80%RCELAvita Medical-2.71%-23.89%+1.02%-29.46%-30.70%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGUTSFractyl Health 2.50Moderate Buy$5.12572.18% UpsideMBOTMicrobot Medical 2.60Moderate Buy$6.63252.39% UpsideMLSSMilestone Scientific 3.00Buy$1.00153.49% UpsideRCELAvita Medical 2.43Hold$7.2583.54% UpsideCurrent Analyst Ratings BreakdownLatest MLSS, MBOT, GUTS, and RCEL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails7/8/2026MBOTMicrobot Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)7/6/2026GUTSFractyl Health Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeSell (E+) ➝ Sell (D-)7/1/2026GUTSFractyl Health Craig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$4.007/1/2026GUTSFractyl Health Craig HallumSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingInitiated CoverageBuy$4.006/30/2026RCELAvita Medical TD CowenSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy6/24/2026RCELAvita Medical Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)6/4/2026GUTSFractyl Health HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$8.006/3/2026MBOTMicrobot Medical Loop CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingSet Price Target$4.005/15/2026RCELAvita Medical Lake Street CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy$3.50 ➝ $6.005/12/2026GUTSFractyl Health Weiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (E+)4/24/2026GUTSFractyl Health HC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$8.00(Data available from 7/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGUTSFractyl Health$90K1,342.71N/AN/A$0.07 per share10.88MBOTMicrobot MedicalN/AN/AN/AN/A$1.15 per shareN/AMLSSMilestone Scientific$8.90M3.92N/AN/A$0.11 per share3.59RCELAvita Medical$71.61M1.70N/AN/A($0.55) per share-7.18Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGUTSFractyl Health-$140.95M-$1.29N/AN/AN/AN/A-4,053.15%-96.41%8/11/2026 (Estimated)MBOTMicrobot Medical-$13.14M-$0.26N/AN/AN/AN/A-21.84%-20.71%8/11/2026 (Estimated)MLSSMilestone Scientific-$6.93M-$0.05N/AN/AN/A-52.01%-60.26%-40.23%N/ARCELAvita Medical-$48.59M-$1.57N/AN/AN/A-62.67%N/A-78.92%8/6/2026 (Estimated)Latest MLSS, MBOT, GUTS, and RCEL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/11/2026Q2 2026GUTSFractyl Health-$0.15N/AN/AN/AN/AN/A8/11/2026Q2 2026MBOTMicrobot Medical-$0.09N/AN/AN/A$0.58 millionN/A8/6/2026Q2 2026RCELAvita Medical-$0.2924N/AN/AN/A$20.25 millionN/A5/14/2026Q1 2026RCELAvita Medical-$0.35-$0.35N/A-$7.00$18.30 million$19.25 million5/13/2026Q1 2026MBOTMicrobot Medical-$0.08-$0.05+$0.03-$0.05$0.30 million$0.11 million5/12/2026Q1 2026GUTSFractyl Health-$0.17$0.06+$0.23$0.06N/AN/ACompare DividendsCompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive GrowthGUTSFractyl HealthN/AN/AN/AN/AN/AMBOTMicrobot MedicalN/AN/AN/AN/AN/AMLSSMilestone ScientificN/AN/AN/AN/AN/ARCELAvita MedicalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGUTSFractyl Health1.414.284.28MBOTMicrobot Medical0.0122.5921.93MLSSMilestone ScientificN/A2.851.86RCELAvita MedicalN/A0.470.38Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGUTSFractyl HealthN/AMBOTMicrobot Medical16.30%MLSSMilestone Scientific5.79%RCELAvita Medical27.66%Insider OwnershipCompanyInsider OwnershipGUTSFractyl Health8.52%MBOTMicrobot Medical4.74%MLSSMilestone Scientific9.22%RCELAvita Medical2.24%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGUTSFractyl Health102158.65 million145.13 millionN/AMBOTMicrobot Medical2067.17 million63.98 millionOptionableMLSSMilestone Scientific3088.45 million58.61 millionOptionableRCELAvita Medical13030.78 million30.09 millionOptionableMLSS, MBOT, GUTS, and RCEL HeadlinesRecent News About These CompaniesAvita Medical (NASDAQ:RCEL) Rating Increased to Hold at Wall Street ZenJuly 4, 2026 | americanbankingnews.comAvita Medical (RCEL) Upgraded to Buy: Here's WhyJuly 3, 2026 | zacks.comAVITA Medical Highlights First U.K. Clinical Experience with RECELL GO at British Burn Association Annual MeetingJune 18, 2026 | markets.businessinsider.comAvita Medical (NASDAQ:RCEL) Director Purchases $20,800.00 in StockJune 11, 2026 | insidertrades.comAvita Medical (NASDAQ:RCEL) Director Purchases $41,900.00 in StockJune 10, 2026 | insidertrades.comAvita Medical (NASDAQ:RCEL) Director Purchases $40,900.00 in StockJune 6, 2026 | insidertrades.comAvita Medical (NASDAQ:RCEL) Director Buys $43,000.00 in StockJune 4, 2026 | insidertrades.comAVITA Medical, Inc. (RCEL) Shareholder/Analyst Call Prepared Remarks TranscriptJune 3, 2026 | seekingalpha.comAVITA Medical, Inc. (RCEL) Discusses Business Progress, Operational Changes and Sequential Revenue Growth TranscriptMay 22, 2026 | seekingalpha.comAVITA Medical to Host Investor Webinar BriefingMay 17, 2026 | globenewswire.comBTIG Reaffirms Their Hold Rating on Avita Medical (RCEL)May 17, 2026 | theglobeandmail.comLake Street upgrades AVITA Medical (RCEL)May 16, 2026 | msn.comAvita (RCEL) Q1 2026 Earnings Call TranscriptMay 15, 2026 | theglobeandmail.comAVITA Medical, Inc. (RCEL) Q1 2026 Earnings Call TranscriptMay 14, 2026 | seekingalpha.comAVITA Medical Reports First Quarter 2026 Financial ResultsMay 14, 2026 | globenewswire.comAVITA Medical Names Cary Vance as Chief Executive OfficerApril 30, 2026 | globenewswire.comAVITA Medical Announces TGA Certification in Australia and Medsafe WAND Listing in New Zealand for RECELL GOApril 29, 2026 | globenewswire.comAVITA Medical to Announce First Quarter 2026 Financial ResultsApril 23, 2026 | globenewswire.comINVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AVITA Medical Inc. - RCELApril 21, 2026 | globenewswire.comAVITA Medical, Inc. (RCEL) Shareholder/Analyst Call TranscriptApril 16, 2026 | seekingalpha.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeMLSS, MBOT, GUTS, and RCEL Company DescriptionsFractyl Health NASDAQ:GUTS$0.76 -0.03 (-3.91%) Closing price 07/13/2026 04:00 PM EasternExtended Trading$0.76 0.00 (-0.09%) As of 07:57 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.Microbot Medical NASDAQ:MBOT$1.88 -0.01 (-0.53%) Closing price 07/13/2026 04:00 PM EasternExtended Trading$1.86 -0.01 (-0.80%) As of 08:09 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Microbot Medical Inc., a pre-clinical medical device company, engages in the research, design, and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. The company offers LIBERTY, an endovascular robotic surgical system which allows physicians to conduct a catheter-based procedure from outside the catheterization laboratory, and avoid radiation exposure, physical strain, and the risk of cross contamination for use in cardiovascular, peripheral, and neurovascular spaces. It also provides NovaCross, an intellectual property and technology in the field of intraluminal revascularization devices with anchoring mechanism and integrated microcatheter. The company has a strategic collaboration agreement with Stryker Corporation for technology co-development. Microbot Medical Inc. was founded in 2010 and is based in Braintree, Massachusetts.Milestone Scientific NYSE:MLSS$0.39 +0.01 (+3.30%) Closing price 07/13/2026 04:00 PM EasternExtended Trading$0.40 +0.00 (+0.13%) As of 07:34 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.Milestone Scientific Inc., a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments. Its products include CompuDent and STA Single Tooth Anesthesia System that are used for all dental procedures that require local anesthetic. In addition, the company offers CompuFlo, a computer-controlled drug delivery system for the painless delivery of drugs, anesthetics, and other medicaments, as well as for the aspiration of bodily fluids or previously injected substances, and disposable injection handpiece for the tactile control during the injection. Further, it provides CompuFlo Epidural, a computer-controlled anesthesia system for use in various medical applications. Additionally, the company offers company offers CompuMed for use in various medical procedures performed in plastic, hair restoration, and colorectal surgery, as well as podiatry, dermatology, orthopedics, and various other disciplines. Milestone Scientific Inc. was incorporated in 1989 and is headquartered in Roseland, New Jersey.Avita Medical NASDAQ:RCEL$3.95 -0.11 (-2.71%) Closing price 07/13/2026 04:00 PM EasternExtended Trading$3.95 0.00 (0.00%) As of 07/13/2026 06:18 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.AVITA Medical, Inc., together with its subsidiaries, operates as a regenerative medicine company in the United States and internationally. The company's lead product is the RECELL System, a cell harvesting device used for the treatment of thermal burn wounds, full-thickness skin defects, and repigmentation of stable depigmented vitiligo lesions. It develops RECELL GO to control the manual process of disaggregation, filtration, and soak time. The company was formerly known as AVITA Therapeutics, Inc. AVITA Medical, Inc. was incorporated in 2020 and is headquartered in Valencia, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSilverSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas The SK Hynix IPO and 2027’s AI Memory Squeeze Why Welltower's Growth Story Might Outrun Its Rich Valuation Why Micron Is Doubling Down While the HBM Shortage Persists AMD's 5C Deal Positions It as a Direct NVIDIA Rival China's Helium Ban Could Reshape the AI Supply Chain The Phase 3 Failure That Sent Biotech Winners and Losers in Opposite Directions Analysts See Major Upside for These 5 Stocks One Short- and One Long-Term ETF for Quantum Computing Bulls Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
